A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia. A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donep ...
A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia. A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donep ...
Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With ...
A 52-week, Multicentre Open Label Extension Study of the Safety Tolerability and Efficacy of Donepezil (Aricept) in Parkinson's Disease (PD) Patients With Dementia A 52-week, Multicentre Open Label Extension Study of the Safety Tolerability and Efficacy of Donepez ...
The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With De ...